Mindler has taken ownership of the UK company, which has been providing digitally delivered talking therapies to the NHS for ...

"We are of course disappointed by the FDA's decision to not approve vatiquinone," said Matthew Klein, PTC's chief executive, who noted that the FDA is seeking another 'adequate and well-controlled' ...